Voisard Asset Management Group »

Crispr Therapeutics shares owned by Voisard Asset Management Group

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Voisard Asset Management Group from 13F filings

Historical chart of Voisard Asset Management Group investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Voisard Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Voisard Asset Management Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $14k 200 68.16
2023-12-31 $13k 200 62.60

More positions owned by Voisard Asset Management Group

J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
Ishares Tr Core Us Aggbd Et (AGG)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Spdr Ser Tr Portfolio S&p600 (SPSM)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Vanguard Index Fds Mid Cap Etf (VO)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Exch Trd Slf Idx Bulshs 2024 Cb (BSCO)

View all positions for Voisard Asset Management Group

Top funds holding Crispr Therapeutics

ARK Investment Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
BlackRock
Citadel Advisors
Vanguard Group
NEA Management Company
Susquehanna International
Caption Management
Dimensional Fund Advisors
Bellevue Group
T. Rowe Price Associates
Bank of America Corporation
Voloridge Investment Management
Ikarian Capital

View all funds holding Crispr Therapeutics